Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway

References

• WuSDuXWuMDuHShiXZhangTMicroRNA-409–3p inhibits osteosarcoma cell migration and invasion by targeting catenin-delta1Gene20165841838926992637
   PubMed Web of Science ®Google Scholar
• O’DayKGorlickRNovel therapeutic agents for osteosarcomaExpert Rev Anticancer Ther20099451152319374604
   PubMed Web of Science ®Google Scholar
• XieCHCaoYMHuangYLong non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9–5p and regulating POU2F1 expressionTumour Biol20163711150311504127658774
   PubMedGoogle Scholar
• SubbiahVWagnerMJMcGuireMFPersonalized comprehensive molecular profiling of high risk osteosarcoma: implications and limitations for precision medicineOncotarget2015638406424065426510912
   PubMedGoogle Scholar
• PetersonTRLaplanteMThoreenCCDEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survivalCell2009137587388619446321
   PubMed Web of Science ®Google Scholar
• SrinivasKPVijiRDanVMDEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinaseOncotarget2016717241542417126992219
   PubMedGoogle Scholar
• WangCYuJTMiaoDWuZCTanMSTanLTargeting the mTOR signaling network for Alzheimer’s disease therapyMol Neurobiol201449112013523853042
   PubMed Web of Science ®Google Scholar
• DannSGSelvarajAThomasGmTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancerTrends Mol Med200713625225917452018
   PubMed Web of Science ®Google Scholar
• DingLCongweiLBeiQmTOR: an attractive therapeutic target for osteosarcoma?Oncotarget2016731508055081327177330
   PubMedGoogle Scholar
• GordonIKYeFKentMSEvaluation of the mammalian target of rapamycin pathway and the effect of rapamycin on target expression and cellular proliferation in osteosarcoma cells from dogsAm J Vet Res20086981079108418672974
   PubMedGoogle Scholar
• LeeDHQiJBradnerJESynergistic effect of JQ1 and rapamycin for treatment of human osteosarcomaInt J Cancer201513692055206425307878
   PubMed Web of Science ®Google Scholar
• DuanSSkaarJRKuchaySmTOR generates an auto-amplification loop by triggering the betaTrCP- and CK1alpha-dependent degradation of DEPTORMol Cell201144231732422017877
   PubMed Web of Science ®Google Scholar
• WangZZhongJInuzukaHAn evolving role for DEPTOR in tumor development and progressionNeoplasia201214536837522745583
   PubMed Web of Science ®Google Scholar
• JiYMZhouXFZhangJDEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosisOncotarget2016712141881419826893358
   PubMedGoogle Scholar
• LiHSunGYZhaoYDEPTOR has growth suppression activity against pancreatic cancer cellsOncotarget2014524128111281925544749
   PubMedGoogle Scholar
• LaiEYChenZGZhouXDEPTOR expression negatively correlates with mTORC1 activity and tumor progression in colorectal cancerAsian Pac J Cancer Prev201415114589459424969890
   PubMedGoogle Scholar
• ZhouXGuoJJiYReciprocal negative regulation between EGFR and DEPTOR plays an important role in the progression of lung adenocarcinomaMol Cancer Res201614544845726896556
   PubMedGoogle Scholar
• Rogers-BroadwayKRChudasamaDPadosGDifferential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitroInt J Oncol201649113314327211906
   PubMed Web of Science ®Google Scholar
• PeiLXiePZhouEYangQLuoYTangZOverexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinomaMol Med Rep20114581782321643629
   PubMed Web of Science ®Google Scholar
• HuYSuHLiuCDEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemiaOncogene20173681038104727593934
   PubMedGoogle Scholar
• CaiXLiuYYangWLong noncoding RNA MALAT1 as a potential therapeutic target in osteosarcomaJ Orthop Res201634693294126575981
   PubMed Web of Science ®Google Scholar
• SongRTianKWangWWangLP53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathwayInt J Surg201520808725936826
   PubMed Web of Science ®Google Scholar
• RenKYaoNWangGVasculogenic mimicry: a new prognostic sign of human osteosarcomaHuman pathol201445102120212925123071
   PubMedGoogle Scholar
• SunBZhangDZhaoNZhaoXEpithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumorsOncotarget2017818305023051027034014
   PubMedGoogle Scholar
• TsukumoYAlainTFonsecaBDNadonRSonenbergNTranslation control during prolonged mTORC1 inhibition mediated by 4E-BP3Nat commun201671177627319316
   PubMedGoogle Scholar
• KansaraMTengMWSmythMJThomasDMTranslational biology of osteosarcomaNat Rev Cancer2014141172273525319867
   PubMed Web of Science ®Google Scholar
• WullschlegerSLoewithRHallMNTOR signaling in growth and metabolismCell2006124347148416469695
   PubMed Web of Science ®Google Scholar
• VanhaesebroeckBGuillermet-GuibertJGrauperaMBilangesBThe emerging mechanisms of isoform-specific PI3K signallingNat Rev Mol Cell Biol201011532934120379207
   PubMed Web of Science ®Google Scholar
• PortaCPaglinoCMoscaATargeting PI3K/Akt/mTOR signaling in cancerFront Oncol201446424782981
   PubMedGoogle Scholar
• PanYZhengMZhongLA preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancerMol Cancer Ther201514240741825519702
   PubMedGoogle Scholar
• GuertinDASabatiniDMDefining the role of mTOR in cancerCancer Cell200712192217613433
   PubMed Web of Science ®Google Scholar
• GupteABakerEKWanSSSystematic screening identifies dual PI3K and mTOR inhibition as a conserved therapeutic vulnerability in osteosarcomaClin Cancer Res201521143216322925862761
   PubMedGoogle Scholar
• LinSShaoNNFanLMaXCPuFFShaoZWEffect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTORJ Huazhong Univ Sci Technolog Med Sci201434688989525480586
   PubMedGoogle Scholar
• GrignaniGPalmeriniEFerraresiVSorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trialLancet Oncol20151619810725498219
   PubMed Web of Science ®Google Scholar
• QiuQJiangJLinLDownregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathwaysInt J Oncol20164862508252027082640
   PubMedGoogle Scholar
• PanicNLarghiAAmoreRSingle nucleotide polymorphisms within the 8Q24 region are not associated with the risk of intraductal papillary mucinous neoplasms of the pancreasJ Gastrointestin Liver Dis201625331131527689194
   PubMed Web of Science ®Google Scholar
• ZhaoYXiongXSunYDEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(betaTrCP) E3 ubiquitin ligase and regulates survival and autophagyMol Cell201144230431622017876
   PubMed Web of Science ®Google Scholar
• LuoZYuGLeeHWThe Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growthCancer Res201272133360337122562464
   PubMed Web of Science ®Google Scholar
• CatenaVBrunoTDe NicolaFDeptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cellsOncotarget2016743705467055827655709
   PubMedGoogle Scholar
• ParvaniJGDavuluriGWendtMKDeptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expressionNeoplasia201517331732825810016
   PubMed Web of Science ®Google Scholar
• CatenaVFanciulliMDeptor: not only a mTOR inhibitorJ Exp Clin Cancer Res20173611228086984
   PubMed Web of Science ®Google Scholar
• JaffeNOsteosarcoma: review of the past, impact on the future. The American experienceCancer Treat Res200915223926220213394
   PubMedGoogle Scholar
• ShiYDaniels-WellsTRFrostPCytotoxic properties of a DEPTOR-mTOR inhibitor in multiple myeloma cellsCancer Res201676195822583127530328
   PubMedGoogle Scholar
• ZhangHChenJZengZQueWZhouLKnockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitroInt J Mol Med20133151127113423503641
   PubMed Web of Science ®Google Scholar
• KangHYShimDKangSSChangSIKimHYProtein kinase B inhibits endostatin-induced apoptosis in HUVECsJ Biochem Mol Biol20063919710416466644
   PubMedGoogle Scholar
• HanBWeiWHuaFRequirement for ERK activity in sodium selenite-induced apoptosis of acute promyelocytic leukemia-derived NB4 cellsJ Biochem Mol Biol200740219620417394769
   PubMedGoogle Scholar